Dyno Therapeutics Signs US$1.8 B Gene Therapy Pact with Roche
By Pratika Pahwa & Michelle Liu
Pharma Deals Review: Vol 2020 Issue 10 (Table of Contents)
Published: 30 Oct-2020
DOI: 10.3833/pdr.v2020.i10.2566 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In its third deal since it emerged from stealth in May 2020, Dyno Therapeutics has entered into a collaboration and license agreement with Roche to develop adeno-associated virus vectors for gene therapies for central nervous system diseases and liver-directed therapies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS